Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063906
Chunk: 394

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 394
---
4 |     |            |     (4 | ) |
| Pro forma intangible assets and goodwill (note ii)     |     | $          | 19,324 |   |

____________ Note i:The fair value of total consideration represents the number of shares of Aptorum expected to be issued in the share exchange at $0.97 per share the average Aptorum share price over the five days ended June 30, 2025. Note ii:The pro forma fair value adjustments to intangible assets mainly arise from the recognition, on a pro forma basis, of in process research and development of Target. The pro forma fair values of the intangible assets are based on estimation by the directors of the Company the assistance of an independent qualified professional valuation advisor using primarily a cost approach. The consideration paid for the Acquisition effectively included amounts in relation to the benefit of expected revenue growth, future market development and the assembled workforce of Target, These benefits are not recognized separately from goodwill because they do not meet the recognition criteria for identifiable intangible assets. Should there be any adverse changes to the business of the Target, including but not limited to, any subsequent adverse changes in the operation, impairment may be required to be recognized against provisional goodwill in accordance with ASC 350 -20-35and the Company’s accounting policies.

247 The Company’s directors confirmed that they will adopt consistent approach to assess impairment of goodwill in subsequent reporting periods in accordance with the requirements of ASC 350 -20-35and will disclose in the Group’s annual report the basis and assumptions adopted by the Company’s directors in the impairment assessment in accordance with the disclosure requirements in ASC 350 -20-35. The pro forma fair values of the identifiable assets and liabilities and goodwill, if any, in relation to the Acquisition are subject to material change upon the completion of a definitive merger agreement and re -determinationof the accounting acquirer and purchase price allocation as of the date any closing, which may be substantially different from their estimated amounts used in the preparation of this unaudited pro forma financial information. Amounts allocated to patents are generally subject to amortization over the lives of the patents, as definite -liveintangible assets. Amounts allocated to in -processresearch and development are subject periodic impairment, including upon the abandonment of programs. Amounts allocated to goodwill are subject to periodic impairment, including upon Company market price declines. (b)The adjustment represents the estimated transaction costs, including legal and professional fees directly attributable to the Acquisition and settled in cash. (c)Convertible notes due to